PA8489901A1 - Derivados de monosacaridos como inhibidores de adhesion celular - Google Patents
Derivados de monosacaridos como inhibidores de adhesion celularInfo
- Publication number
- PA8489901A1 PA8489901A1 PA20008489901A PA8489901A PA8489901A1 PA 8489901 A1 PA8489901 A1 PA 8489901A1 PA 20008489901 A PA20008489901 A PA 20008489901A PA 8489901 A PA8489901 A PA 8489901A PA 8489901 A1 PA8489901 A1 PA 8489901A1
- Authority
- PA
- Panama
- Prior art keywords
- cell adhesion
- derivatives
- compounds
- adhesion inhibitors
- isopropilideno
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H9/00—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
- C07H9/02—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing only oxygen as ring hetero atoms
- C07H9/04—Cyclic acetals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Pulmonology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Rheumatology (AREA)
- Endocrinology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Dermatology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Transplantation (AREA)
- Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN86DE1999 IN190975B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1999-01-15 | 1999-01-15 | |
| US09/276,368 US6590085B1 (en) | 1999-01-15 | 1999-03-25 | Derivatives of monosaccharides as cell adhesion inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PA8489901A1 true PA8489901A1 (es) | 2000-09-29 |
Family
ID=11088155
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PA20008489901A PA8489901A1 (es) | 1999-01-15 | 2000-01-14 | Derivados de monosacaridos como inhibidores de adhesion celular |
Country Status (30)
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IN190975B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * | 1999-01-15 | 2003-09-06 | Ranbaxy Lab Ltd | |
| AU2004242777B2 (en) | 2003-05-30 | 2011-05-12 | Ranbaxy Laboratories Limited | Substituted pyrrole derivatives and their use as HMG-Co inhibitors |
| WO2006024926A1 (en) * | 2004-09-02 | 2006-03-09 | Ranbaxy Laboratories Limited | Monosaccharide derivatives |
| WO2007063356A2 (en) * | 2004-12-22 | 2007-06-07 | Ranbaxy Laboratories Limited | Derivatives of pentose monosaccharides as anti-inflammatory compounds |
| US20090054519A1 (en) * | 2005-07-22 | 2009-02-26 | Abhijit Ray | Derivatives of monosaccharides as 5-lipoxygenase inhibitors |
| KR101329112B1 (ko) * | 2005-11-08 | 2013-11-14 | 랜박시 래보러터리스 리미티드 | (3ｒ,5ｒ)-7-〔2-(4-플루오로페닐)-5-이소프로필-3-페닐-4-〔(4-히드록시 메틸 페닐 아미노)카르보닐〕-피롤-1-일〕-3,5-디히드록시 헵탄산 헤미 칼슘염의 제조 방법 |
| CL2007000667A1 (es) * | 2006-03-14 | 2008-03-14 | Ranbaxi Lab Ltd | Composicion farmaceutica que comprende al acido 7-[2-(4-fluorofenil)-5-isopropil-3-fenil-4-[(4-hidroximetilfenilamino)carbonil]pirrol-1-il]-3,5-dihidroxi-heptanoico o una sal y al menos un agente estabilizante; procedimiento de preparacion, util en e |
| EP1842855A3 (en) * | 2006-03-29 | 2007-12-05 | Ranbaxy Laboratories Limited | Monosaccharide derivatives as anti-inflammatory and/or anti-cancer agents |
| US7790689B2 (en) * | 2006-05-30 | 2010-09-07 | Ranbaxy Laboratories Limited | Monosaccharide derivatives |
| EP1953170A1 (en) * | 2006-10-03 | 2008-08-06 | Ranbaxy Laboratories Limited | Monosaccharide derivatives as anti-inflammatory agents |
| AU2008221506B2 (en) * | 2007-09-20 | 2011-01-20 | ResMed Pty Ltd | Retractable Tube for CPAP |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2715121A (en) | 1950-09-09 | 1955-08-09 | American Home Prod | Alkyl sugar derivatives and their preparation |
| US4056322A (en) | 1973-12-14 | 1977-11-01 | Strategic Medical Research Corporation | Preparation of ethers of monosaccharides |
| US4735934A (en) | 1981-02-17 | 1988-04-05 | Greenwich Pharmaceuticals Incorporated | Method of therapeutically treating a warm blooded animal afflicted with an autoimmune disease |
| US4996195A (en) * | 1989-01-09 | 1991-02-26 | Greenwich Pharmaceuticals Inc. | Derivatives of α,D-glucofuranose or α,D-allofuranose and intermediates for preparing these derivatives |
| US5010058A (en) * | 1989-06-22 | 1991-04-23 | 501 Greenwich Pharmaceuticals Incorporated | 3,5,6-substituted derivatives of 1,2-O-isopropylidene-α,D-glucofuranose and intermediates for preparing these derivatives |
| FR2652540B1 (fr) | 1989-10-02 | 1995-06-02 | Imaje Sa | Circuit d'encre notamment destine a la mise en pression d'une encre a pigments pour imprimante a jet d'encre. |
| US5192746A (en) | 1990-07-09 | 1993-03-09 | Tanabe Seiyaku Co., Ltd. | Cyclic cell adhesion modulation compounds |
| US5258402A (en) | 1992-06-11 | 1993-11-02 | Mcneil-Ppc, Inc. | Imidate derivatives of pharmaceutically useful anticonvulsant sulfamates |
| US5432163A (en) | 1992-11-13 | 1995-07-11 | Greenwich Pharmaceuticals Incorporated | Anti-proliferative and anti-inflammatory compounds: derivatives of pentose monosaccharides |
| US5637570A (en) * | 1995-05-09 | 1997-06-10 | Chemora Pharmochem | Disubstituted and trisubstituted derivatives of 2,3:4,6-di-O-isopropylidene-α-L-xylo-2-hexulofuranosonic acid having anti-cancer, anti-inflammatory and anti-proliferative activity |
| IN190975B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * | 1999-01-15 | 2003-09-06 | Ranbaxy Lab Ltd |
-
1999
- 1999-01-15 IN IN86DE1999 patent/IN190975B/en unknown
- 1999-03-25 US US09/276,368 patent/US6590085B1/en not_active Expired - Fee Related
-
2000
- 2000-01-10 ES ES00900088T patent/ES2206176T3/es not_active Expired - Lifetime
- 2000-01-10 AT AT00900088T patent/ATE250074T1/de not_active IP Right Cessation
- 2000-01-10 CN CNB008048525A patent/CN1167707C/zh not_active Expired - Fee Related
- 2000-01-10 YU YU50701A patent/YU50701A/sh unknown
- 2000-01-10 NZ NZ512852A patent/NZ512852A/xx unknown
- 2000-01-10 BR BR0007553-1A patent/BR0007553A/pt not_active IP Right Cessation
- 2000-01-10 PT PT00900088T patent/PT1147119E/pt unknown
- 2000-01-10 WO PCT/IB2000/000022 patent/WO2000042054A1/en active IP Right Grant
- 2000-01-10 EP EP00900088A patent/EP1147119B1/en not_active Expired - Lifetime
- 2000-01-10 DK DK00900088T patent/DK1147119T3/da active
- 2000-01-10 HR HR20010529A patent/HRP20010529B1/xx not_active IP Right Cessation
- 2000-01-10 AU AU18861/00A patent/AU768511B2/en not_active Ceased
- 2000-01-10 NZ NZ527483A patent/NZ527483A/en unknown
- 2000-01-10 CZ CZ20012540A patent/CZ20012540A3/cs unknown
- 2000-01-10 TR TR2001/02043T patent/TR200102043T2/xx unknown
- 2000-01-10 AR ARP000100086A patent/AR022235A1/es not_active Application Discontinuation
- 2000-01-10 DE DE60005300T patent/DE60005300T2/de not_active Expired - Fee Related
- 2000-01-10 MX MXPA01007187A patent/MXPA01007187A/es not_active IP Right Cessation
- 2000-01-10 JP JP2000593621A patent/JP2002534530A/ja active Pending
- 2000-01-10 CA CA002359986A patent/CA2359986A1/en not_active Abandoned
- 2000-01-10 SK SK10132001A patent/SK284241B6/sk unknown
- 2000-01-10 ID IDW00200101520A patent/ID30351A/id unknown
- 2000-01-10 HU HU0105116A patent/HUP0105116A3/hu unknown
- 2000-01-14 CO CO00001575A patent/CO5180591A1/es not_active Application Discontinuation
- 2000-01-14 PA PA20008489901A patent/PA8489901A1/es unknown
- 2000-01-14 MY MYPI20000121A patent/MY121135A/en unknown
-
2001
- 2001-07-12 CR CR6423A patent/CR6423A/xx not_active Application Discontinuation
- 2001-07-12 MA MA26266A patent/MA25342A1/fr unknown
- 2001-07-26 BG BG105745A patent/BG105745A/xx unknown
-
2003
- 2003-07-01 US US10/611,386 patent/US7005516B2/en not_active Expired - Fee Related
- 2003-07-01 US US10/611,091 patent/US20040018995A1/en not_active Abandoned
- 2003-07-01 US US10/611,093 patent/US7005422B2/en not_active Expired - Fee Related
- 2003-07-01 US US10/610,719 patent/US7037899B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PA8489901A1 (es) | Derivados de monosacaridos como inhibidores de adhesion celular | |
| MX2019007708A (es) | Nuevos agentes anti-inflamatorios. | |
| ES2183937T3 (es) | Inhibidores de la adhesion celular. | |
| EA199800119A1 (ru) | Ингибиторы адгезии клеток | |
| UY27437A1 (es) | Compuestos químicos | |
| BR0208667A (pt) | Antagonistas da função de mcp-1 e métodos de uso dos mesmos | |
| ECSP055856A (es) | Derivados de 3-aminopirrolidina como moduladores de receptores de quimocina | |
| BR0009869A (pt) | Método para inibir a produção e/ou secreção de citoquina, e, composição farmacêutica | |
| AR011168A1 (es) | Compuestos derivados del acido hexanoico, composiciones que los contiene, y procedimiento de tratamiento | |
| ES8802386A1 (es) | Procedimiento para prepara (1,2,4)-triazolo (1,5-c)quinazolinas | |
| BR9713993A (pt) | Pirazóis como inibidores de fosfolipase a2 secretora não pancreática humana | |
| MX2010007024A (es) | Tioéteres c-21 como agonista del receptor de glucocorticoides. | |
| ES8305681A1 (es) | Procedimiento para la obtencion de fenileteres sustituidos. | |
| ES8406448A1 (es) | Procedimiento para la preparacion de fenilsulfoniloxibencimidazolcarbamatos sustituidos | |
| IL152961A0 (en) | Inhibitors of alpha beta 2 mediated cell adhesion | |
| AR023546A1 (es) | Disulfuros ciclicos de pirrolidincarbonilamina | |
| ES8604223A1 (es) | Un procedimiento para preparar derivados de purina | |
| ES8500318A1 (es) | Esteres de halofenilgliceridos | |
| ECSP088516A (es) | Procedimiento graduable para la preparacion de un 42-ester de rapamicina a partir de un boronato de 42-ester de rapamicina | |
| ES8607960A1 (es) | Procedimiento para preparar acidos aroil-benzofuran y benzo-tiofen-aceticos y-propionicos | |
| ES8203824A1 (es) | Procedimiento para preparar esteres de 2-nitro-5-fenoxi sustituido)benzoato de alfa-hidroxialcanoatos | |
| BR9810705A (pt) | Processo para a produção de metacrilato de metila | |
| GT200100021A (es) | Nuevos derivados de amidas heterociclicas. | |
| GB202205674D0 (en) | Electrolutic cell for the production of hypochlorous acid | |
| AR223017A1 (es) | Nuevo procedimiento para la produccion del ester del guayacol del acido acetilsalicilico |